SMTL ID : 9h7m.1

Human Transthyretin in Complex with 4-(quinolin-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.27 Å

Oligo State

homo-tetramer

Ligands

4 x CA: CALCIUM ION(Non-covalent)

CA.1: 2 residues within 4Å: Chain A: E.66, D.99 5 PLIP interactions: 2 interactions with chain A, 3 Ligand-Water interactions Metal complexes: A:E.66, A:D.99, H2O.3, H2O.3, H2O.3 CA.4: 3 residues within 4Å: Chain B: E.66, N.98, D.99 3 PLIP interactions: 2 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:E.66, B:D.99, H2O.3 CA.5: 2 residues within 4Å: Chain C: E.66, D.99 5 PLIP interactions: 2 interactions with chain C, 3 Ligand-Water interactions Metal complexes: C:E.66, C:D.99, H2O.7, H2O.8, H2O.8 CA.8: 3 residues within 4Å: Chain D: E.66, N.98, D.99 3 PLIP interactions: 2 interactions with chain D, 1 Ligand-Water interactions Metal complexes: D:E.66, D:D.99, H2O.8

4 x 01: 4-quinolin-8-yl-1H-pyrazolo[3,4-d]pyrimidin-6-amine

01.2: 14 residues within 4Å: Chain A: L.17, A.108, L.110, S.117, T.118, T.119 Chain C: K.15, L.17, A.108, L.110, S.117, T.118, T.119 Ligands: 01.6 12 PLIP interactions: 6 interactions with chain C, 6 interactions with chain A Hydrophobic interactions: C:K.15, C:L.17, C:A.108, A:L.17, A:A.108 Hydrogen bonds: C:T.119, A:L.110, A:S.117 Water bridges: C:S.117, C:S.117, A:S.117, A:S.117 01.3: 16 residues within 4Å: Chain B: K.15, L.17, A.108, A.109, L.110, S.117, T.118, T.119 Chain D: L.17, A.108, A.109, L.110, S.117, T.118, T.119 Ligands: 01.7 14 PLIP interactions: 9 interactions with chain B, 5 interactions with chain D Hydrophobic interactions: B:K.15, B:L.17, B:A.108, D:L.17, D:A.108 Hydrogen bonds: B:L.110, B:S.117, D:A.108, D:L.110, D:S.117 Water bridges: B:S.117, B:S.117, B:S.117, B:S.117 01.6: 14 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, S.117, T.118, T.119 Chain C: L.17, A.108, L.110, S.117, T.118, T.119 Ligands: 01.2 12 PLIP interactions: 6 interactions with chain C, 6 interactions with chain A Hydrophobic interactions: C:L.17, C:A.108, A:K.15, A:L.17, A:A.108 Hydrogen bonds: C:L.110, C:S.117, A:T.119 Water bridges: C:S.117, C:S.117, A:S.117, A:S.117 01.7: 16 residues within 4Å: Chain B: L.17, A.108, A.109, L.110, S.117, T.118, T.119 Chain D: K.15, L.17, A.108, A.109, L.110, S.117, T.118, T.119 Ligands: 01.3 14 PLIP interactions: 5 interactions with chain B, 9 interactions with chain D Hydrophobic interactions: B:L.17, B:A.108, D:K.15, D:L.17, D:A.108 Hydrogen bonds: B:A.108, B:L.110, B:S.117, D:L.110, D:S.117 Water bridges: D:S.117, D:S.117, D:S.117, D:S.117

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, W., Fragment-Based Drug Discovery for Transthyretin Kinetic Stabilisers Using a Novel Capillary Zone Electrophoresis Method. Biorxiv (2025)

Release Date

2025-03-12

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence